Exacerbation of recurrent depression as a result of treatment with varenicline.
Michael K
MK
Popkin
D000368:Aged; D001552:Benzazepines / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000139:chemically induced* / Q000175:diagnosis / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D018722:Nicotinic Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D011810:Quinoxalines / Q000009:adverse effects* / Q000627:therapeutic use; D011978:Receptors, Nicotinic / Q000187:drug effects*; D012008:Recurrence; D016540:Smoking Cessation; D000068580:Varenicline
D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D011978:Receptors, Nicotinic; C403531:nicotinic receptor alpha4beta2; D000068580:Varenicline